Prostate Cancer
Clinical trial risk in castration resistant prostate cancer: Immunotherapies show promise - Abstract
October 17, 2013
Men with intermediate-risk prostate cancer have excellent outcomes with short course hormonal therapy
October 17, 2013
The potential impact of adding genetic markers to clinical parameters in managing high-risk prostate cancer patients - Abstract
October 16, 2013
A case on hemodialysis with castration-resistant prostate cancer which responded to combination chemotherapy with docetaxel and prednisolone - Abstract
October 16, 2013
Lifetime body size and prostate cancer risk in a population-based case-control study in Sweden - Abstract
October 16, 2013
Role of step size and max dwell time in anatomy based inverse optimization for prostate implants - Abstract
October 16, 2013
Admixture mapping of prostate cancer in African Americans participating in the North Carolina-Louisiana Prostate Cancer Project (PCaP) - Abstract
October 15, 2013
Seminal vesicle biopsies: An useful staging procedure-exposure of seminal vesicle biopsies protocol and review of the literature - Abstract
October 15, 2013
The presence of prostate cancer at biopsy is predicted by a number of genetic variants - Abstract
October 15, 2013
The value of personalised risk information: A qualitative study of the perceptions of patients with prostate cancer - Abstract
October 15, 2013
Utility of ADC measurement on diffusion-weighted MRI in differentiation of prostate cancer, normal prostate and prostatitis - Abstract
October 15, 2013
The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy - Abstract
October 15, 2013